Redox Intermediates of Flavonoids and Caffeic Acid Esters from Propolis: an EPR Spectroscopy and Cyclic Voltammetry Study
Overview
Biology
General Medicine
Affiliations
The redox properties of flavonoids: chrysin (1), tectochrysin (2), galangin (3), isalpinin (4), pinostrobin (5), pinobanksin (6), pinobanksin-3-acetate (7), and of caffeic acid ester (8) and diacetylcaffeic acid ester (9), all isolated from propolis, were investigated by cyclic voltammetry in acetonitrile. The choice of aprotic solvent lowered the reactivity of the radical intermediates and made possible to identify redox steps and intermediates not detected so far. The oxidation potentials (vs. saturated calomel electrode) of the investigated compounds were in the region of 1.5 V for 3 and 4; 1.9 V for 1, 2, and 5; 2.0 V for 6 and 7; 1.29 V for 8; and 2.3 V for 9. These oxidation potentials were mainly influenced by the presence of a double bond in 2,3-position and substituent R1 in position 3. Comparison with our earlier data revealed that flavonoids, 1-4, and caffeic acid ester 8 with lower oxidation potentials showed the maximal lipid antioxidant activity, whereas those with higher potentials (5, 6, 7, and 9) are less active. On reduction of 1-9 several one-electron-steps were typically observed in the potential regions: -1.5 V, -1.8 V, and -2 V. where in simultaneous EPR experiments anion radicals of 1 and 3 were observed with the center of unpaired spin density on ring A. Upon oxidation of flavonoids 1-4 carbonyl carbon-centered radicals, .C(O)R, were identified as consecutive products using the EPR spin trapping technique.
Yao X, Chen Y, Li Y, Mo J, Liu X, Wang P Int J Colorectal Dis. 2025; 40(1):57.
PMID: 40035853 PMC: 11880046. DOI: 10.1007/s00384-025-04843-8.
Ma J, Liu P, Pan L Discov Oncol. 2025; 16(1):228.
PMID: 39987541 PMC: 11847756. DOI: 10.1007/s12672-025-01951-3.
Electrochemistry of Flavonoids.
Narog D, Sobkowiak A Molecules. 2023; 28(22).
PMID: 38005343 PMC: 10674230. DOI: 10.3390/molecules28227618.
Anti-cancer Activity of Chrysin in Cancer Therapy: a Systematic Review.
Salari N, Faraji F, Jafarpour S, Faraji F, Rasoulpoor S, Dokaneheifard S Indian J Surg Oncol. 2023; 13(4):681-690.
PMID: 36687219 PMC: 9845454. DOI: 10.1007/s13193-022-01550-6.
Jung G, Lee J, Han S, Woo J, Choi E, Jeon S Int J Mol Sci. 2022; 23(24).
PMID: 36555388 PMC: 9778784. DOI: 10.3390/ijms232415747.